|
Guidelines for Covariate Adjustment in RCTs
|
|
62
|
26957
|
October 9, 2022
|
|
Language regarding confidence in "negative" results
|
|
0
|
553
|
October 5, 2022
|
|
Run-in phase in RCTs
|
|
10
|
9386
|
September 24, 2022
|
|
Sample size linear regression
|
|
3
|
1906
|
September 18, 2022
|
|
Can I conduct an exploratory cross-over study on data originally collected in a clinical trial?
|
|
0
|
579
|
September 7, 2022
|
|
Cdisc in academia
|
|
1
|
796
|
September 7, 2022
|
|
From observed event rates to event rate per anno and 5-year risk
|
|
1
|
795
|
August 31, 2022
|
|
How can the change in exposure be taken into account in the survival analysis?
|
|
1
|
662
|
August 12, 2022
|
|
Inventory/Cost of Goods
|
|
1
|
1815
|
July 9, 2022
|
|
Predicting rare outcomes
|
|
8
|
4637
|
June 26, 2022
|
|
Discussion on reconstructing data
|
|
4
|
4042
|
June 22, 2022
|
|
Article(s): Coffee Benefits and Continuous vs. Categorical Variable Analysis
|
|
3
|
1672
|
June 19, 2022
|
|
Study Design for Subjective Multinomial Outcome
|
|
7
|
2694
|
June 6, 2022
|
|
What type of study design can best describe this Study?
|
|
0
|
1139
|
June 2, 2022
|
|
Should adverse effects be adjusted for multiple comparisons?
|
|
4
|
2485
|
May 24, 2022
|
|
Predictive modelling of crossover trial with a binary outcome and four interventions
|
|
0
|
1143
|
May 12, 2022
|
|
Prospective OR Retrospective Cohort Study?
|
|
3
|
3876
|
May 8, 2022
|
|
What are the decision rules for concluding on the effectiveness of the treatment when intermediate analyses are planned?
|
|
6
|
1674
|
May 8, 2022
|
|
Summary Statistics vs Raw Data
|
|
8
|
8276
|
May 7, 2022
|
|
Is logistic regression or survival analysis most appropriate in this case?
|
|
1
|
1373
|
April 28, 2022
|
|
Statistical power estimation for a time-dependent covariate in Cox (proportional hazards) regression
|
|
0
|
1242
|
April 19, 2022
|
|
Methodology: Benefit Risk Assessment when Risk and Benefit are only observed in different timing
|
|
5
|
1440
|
April 18, 2022
|
|
Do we need a research hypothesis for developing a clinical prediction model?
|
|
7
|
1980
|
April 9, 2022
|
|
Article: Going from evidence to recommendations: Can GRADE get us there?
|
|
0
|
1366
|
April 3, 2022
|
|
Exemplary QOL analyses that avoid change-from-baseline blunders?
|
|
22
|
12819
|
March 10, 2022
|
|
Interesting Talk on Dichotomization
|
|
9
|
2549
|
March 2, 2022
|
|
Outcome dispersion and reduction of outliers as a primary outcome in clinical RCT?
|
|
3
|
1768
|
February 24, 2022
|
|
Understanding "BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting]"
|
|
0
|
1568
|
January 18, 2022
|
|
RCT - baseline measures and group x time interaction without main effect for group?
|
|
6
|
3294
|
January 1, 2022
|
|
Catastrophic Heterogeneity Meets "The Clairvoyant RCT"
|
|
0
|
1613
|
December 28, 2021
|